INS and type 2 diabetes mellitus: However, whereas T2D subjects develop impaired insulin secretion, T1D subjects may also develop IR, as a complex result of interactions among age, sex, pregnancy, ethnicity, duration of disease, increased life expectancy, genetic predisposition, epigenetic changes, glucotoxicity, lipotoxicity, overweight and intensive insulin therapy [2,3,4,5].